Balance Sheet
Cash Flow Statement
Beginning Cash BalanceGains from Sales and Divestitures
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Shares Issued: 2012-2023

Historic Shares Issued for RedHill Biopharma (RDHL) over the last 5 years, with Jun 2023 value amounting to $5.0 million.

  • RedHill Biopharma's Shares Issued fell 67.51% to $5.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was $28.8 million, marking a year-over-year decrease of 21.07%. This contributed to the annual value of $8.3 million for FY2024, which is 40.81% down from last year.
  • RedHill Biopharma's Shares Issued amounted to $5.0 million in Q2 2023, which was down 33.58% from $7.6 million recorded in Q4 2022.
  • RedHill Biopharma's 5-year Shares Issued high stood at $57.9 million for Q1 2021, and its period low was $273,000 during Q2 2021.
  • In the last 3 years, RedHill Biopharma's Shares Issued had a median value of $6.3 million in 2022 and averaged $13.4 million.
  • Over the last 5 years, RedHill Biopharma's Shares Issued had its largest YoY gain of 5,580.59% in 2022, and its largest YoY loss of 98.77% in 2022.
  • RedHill Biopharma's Shares Issued (Quarterly) stood at $8.4 million in 2020, then skyrocketed by 136.92% to $19.8 million in 2021, then plummeted by 61.74% to $7.6 million in 2022, then crashed by 67.51% to $5.0 million in 2023.
  • Its Shares Issued was $5.0 million in Q2 2023, compared to $7.6 million in Q4 2022 and $15.5 million in Q2 2022.